effect of propofol and sevofluran on cerebral oxygenation in patients undergoing off pump coronary artery bypass grafting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201307242963N15

Enrollment

Registered

2013-08-13

Start date

2013-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic heart diseases. Ischaemic heart diseases

Interventions

Intervention 1: case group:propofol 3_5 mg.kg. Intervention 2: control group: sevofluran 1.5_2%.

Treatment - Drugs

case group:propofol 3_5 mg.kg

control group: sevofluran 1.5_2%

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: including criteria:all patients undergoing for off pump coronary artery bypass grafting. excluding criteria: liver disease ? renal disease ? nourologic disease ? CVA ?EF<30%

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cerebral oxygenation. Timepoint: before, during and after of grafts. Method of measurement: INVOS.	—

Secondary

Measure	Time frame
HR. Timepoint: befoe, during and after of grafts. Method of measurement: ECG.;MAP. Timepoint: before,during and after of grafts. Method of measurement: barometer.;CVP. Timepoint: before, during,after of grafts. Method of measurement: arterial catheter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr shekufeh behdad

shahid sadoughi medical sciences university

drbehdad@ssu.ac.ir+98 35 1822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026